'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program but also Medicaid and Medicare Part B if manufacturers implement a cash replenishment model, counsel for Eli Lilly—the manufacturer of Mounjaro, Trulicity and other treatments for weight loss or diabetes—alleged in their complaint.
How I Made Law Firm Leadership: 'Leaders Must Be Good Listeners,' Says Dan Summerlin of Woods Rogers
"You need a vision of what you want your firm to accomplish, but at the same time, you must be willing to listen and remain open to your partners and their views. Leaders must be good listeners. People want to be heard, and leaders must respect their opinions. You may not always agree, but it is critical that they feel they have been heard."